KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520,492 | +9.9% | 4,487 | +11.2% | 0.00% | 0.0% |
| Q2 2023 | $473,709 | +116.2% | 4,035 | +47.4% | 0.00% | +100.0% |
| Q1 2023 | $219,124 | -15.1% | 2,737 | -16.0% | 0.00% | 0.0% |
| Q4 2022 | $258,020 | -9.5% | 3,257 | -20.3% | 0.00% | -50.0% |
| Q3 2022 | $285,000 | +6.3% | 4,089 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $268,000 | -2.2% | 4,089 | -0.9% | 0.00% | +100.0% |
| Q1 2022 | $274,000 | -14.1% | 4,125 | -9.4% | 0.00% | -50.0% |
| Q4 2021 | $319,000 | +538.0% | 4,555 | +378.5% | 0.00% | – |
| Q3 2021 | $50,000 | -21.9% | 952 | +1.2% | 0.00% | – |
| Q2 2021 | $64,000 | -7.2% | 941 | +4.3% | 0.00% | – |
| Q1 2021 | $69,000 | – | 902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |